SPESOLIMAB-SBZO

SPESOLIMAB-SBZO was reported 334 times

SPESOLIMAB-SBZO is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GENERALISED PUSTULAR PSORIASIS 71 0.2448
1 PARANEOPLASTIC DERMATOSIS 1 0.2000
2 KERION 1 0.0769
3 DERMATOLOGIC EXAMINATION ABNORMAL 1 0.0455
4 PARATHYROID GLAND OPERATION 3 0.0200
5 LEIOMYOSARCOMA METASTATIC 1 0.0147
6 MEDICAL DEVICE SITE ABSCESS 1 0.0145
7 VEXAS SYNDROME 1 0.0104
8 PALMOPLANTAR PUSTULOSIS 4 0.0076
9 HYPOBARISM 1 0.0067
10 CARDIAC PACEMAKER REPLACEMENT 3 0.0065
11 PUSTULE 15 0.0063
12 RADIAL NERVE PALSY 2 0.0057
13 STAPHYLOCOCCAL SCALDED SKIN SYNDROME 1 0.0044
14 INFESTATION 1 0.0039
15 LYMPHOMATOID PAPULOSIS 1 0.0034
16 EXCESSIVE CERUMEN PRODUCTION 2 0.0032
17 MUSCLE ABSCESS 2 0.0032
18 WOUND INFECTION PSEUDOMONAS 1 0.0032
19 PROCEDURAL HEADACHE 1 0.0024
20 CORNEAL DYSTROPHY 1 0.0024
21 ADRENAL NEOPLASM 1 0.0021
22 FAECAL VOLUME DECREASED 1 0.0021
23 OCCIPITAL NEURALGIA 1 0.0018
24 ABDOMINAL WALL ABSCESS 1 0.0015
25 PUSTULAR PSORIASIS 5 0.0015
26 NONINFECTIVE GINGIVITIS 2 0.0014
27 SOLAR LENTIGO 1 0.0011
28 KLEBSIELLA BACTERAEMIA 1 0.0011
29 INJECTION SITE SCAB 1 0.0010
30 LYMPHADENECTOMY 1 0.0010
31 CARDIAC DEATH 1 0.0008
32 SKIN FRAGILITY 2 0.0008
33 POST-ACUTE COVID-19 SYNDROME 1 0.0008
34 MAST CELL ACTIVATION SYNDROME 1 0.0007
35 PULMONARY SEPSIS 1 0.0007
36 IMMUNE-MEDIATED MYOCARDITIS 1 0.0006
37 COSTOCHONDRITIS 1 0.0006
38 INJECTION SITE CELLULITIS 1 0.0005
39 LIP DISORDER 1 0.0005
40 HYPOPROTEINAEMIA 1 0.0005
41 GINGIVAL RECESSION 1 0.0005
42 DEVICE RELATED SEPSIS 1 0.0005
43 EYE CONTUSION 1 0.0005
44 SLEEP DEFICIT 1 0.0005
45 BLOOD CREATINE INCREASED 2 0.0005
46 URINARY TRACT DISORDER 2 0.0004
47 ESCHERICHIA BACTERAEMIA 1 0.0004
48 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 1 0.0004
49 INFREQUENT BOWEL MOVEMENTS 1 0.0004
50 DRUG TOLERANCE 2 0.0004
51 ENDODONTIC PROCEDURE 1 0.0004
52 APPENDICITIS PERFORATED 1 0.0004
53 SKIN WRINKLING 1 0.0004
54 INVASIVE DUCTAL BREAST CARCINOMA 1 0.0004
55 DUODENAL ULCER HAEMORRHAGE 1 0.0003
56 SKIN ATROPHY 2 0.0003
57 BACTERIAL SEPSIS 1 0.0003
58 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
59 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
60 BRONCHIOLITIS 1 0.0003
61 HAEMORRHAGIC DIATHESIS 1 0.0003
62 SKIN WEEPING 1 0.0003
63 PYODERMA GANGRENOSUM 1 0.0003
64 CLAVICLE FRACTURE 1 0.0003
65 FAECES HARD 1 0.0003
66 GALLBLADDER OPERATION 1 0.0002
67 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
68 ARTHRITIS BACTERIAL 1 0.0002
69 ANAPHYLACTOID REACTION 1 0.0002
70 HYPERPYREXIA 1 0.0002
71 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
72 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
73 ROSACEA 1 0.0002
74 FLANK PAIN 2 0.0002
75 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
76 INFLAMMATORY MARKER INCREASED 1 0.0002
77 VEIN DISORDER 1 0.0002
78 PERIORBITAL OEDEMA 1 0.0002
79 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
80 NONSPECIFIC REACTION 1 0.0002
81 MICTURITION URGENCY 2 0.0002
82 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
83 ENERGY INCREASED 1 0.0002
84 HEPATITIS B 1 0.0002
85 INFUSION SITE EXTRAVASATION 1 0.0002
86 SWELLING OF EYELID 1 0.0002
87 IMMUNE SYSTEM DISORDER 2 0.0002
88 CARDIAC FAILURE ACUTE 1 0.0001
89 MENINGITIS 1 0.0001
90 DERMATITIS 3 0.0001
91 PAPULE 1 0.0001
92 RASH PUSTULAR 1 0.0001
93 SKIN HAEMORRHAGE 2 0.0001
94 HEPATOCELLULAR CARCINOMA 1 0.0001
95 BOWEL MOVEMENT IRREGULARITY 1 0.0001
96 PROCEDURAL COMPLICATION 1 0.0001
97 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
98 HYPOALBUMINAEMIA 1 0.0001
99 AFFECTIVE DISORDER 1 0.0001
100 FURUNCLE 1 0.0001
101 EOSINOPHIL COUNT INCREASED 1 0.0001
102 INFUSION SITE ERYTHEMA 1 0.0001
103 FACIAL PARALYSIS 1 0.0001
104 HYSTERECTOMY 1 0.0001
105 PSORIASIS 15 0.0001
106 PAIN OF SKIN 3 0.0001
107 HIDRADENITIS 1 0.0001
108 SKIN LESION 3 0.0001
109 UROSEPSIS 1 0.0001
110 WOUND 3 0.0001
111 ERYTHEMA MULTIFORME 1 0.0001
112 NEPHROPATHY 1 0.0001
113 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
114 BODY TEMPERATURE DECREASED 1 0.0001
115 HOSPICE CARE 1 0.0001
116 PRODUCT ADMINISTRATION ERROR 2 0.0001
117 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 7 0.0001
118 DECREASED ACTIVITY 1 0.0001
119 IMPAIRED HEALING 3 0.0001
120 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
121 SKIN DISORDER 3 0.0001
122 SKIN INFECTION 1 0.0001
123 INTESTINAL PERFORATION 1 0.0001
124 DERMATITIS CONTACT 1 0.0001
125 INTERNAL HAEMORRHAGE 1 0.0001
126 METASTASES TO LUNG 1 0.0001
127 ELECTROLYTE IMBALANCE 1 0.0001
128 SKIN EXFOLIATION 7 0.0001
129 THERAPEUTIC RESPONSE DECREASED 5 0.0001
130 SPINAL OPERATION 1 0.0001
131 HYPERCALCAEMIA 1 0.0001
132 PNEUMONIA ASPIRATION 2 0.0001
133 INTENTIONAL PRODUCT USE ISSUE 7 0.0001
134 MATERNAL EXPOSURE DURING PREGNANCY 7 0.0001
135 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
136 INFLAMMATION 4 0.0001
137 TACHYPNOEA 1 0.0001
138 GINGIVAL BLEEDING 1 0.0001
139 ANAPHYLACTIC REACTION 4 0.0001
140 ORAL DISCOMFORT 1 0.0001
141 HYPOMAGNESAEMIA 1 0.0001
142 SEPSIS 8 0.0001
143 BLISTER 4 0.0001
144 INTENTIONAL DOSE OMISSION 2 0.0001
145 APATHY 1 0.0001
146 URINARY TRACT INFECTION 11 0.0001
147 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 11 0.0001
148 METASTASES TO BONE 1 0.0001
149 STAPHYLOCOCCAL INFECTION 2 0.0001
150 GAIT INABILITY 2 0.0001
151 CELLULITIS 3 0.0001
152 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
153 ECZEMA 3 0.0001
154 RASH MACULAR 2 0.0001
155 AMENORRHOEA 1 0.0001
156 METASTASES TO LIVER 1 0.0001
157 DRUG ERUPTION 1 0.0001
158 SKIN BURNING SENSATION 4 0.0001
159 OSTEOMYELITIS 1 0.0001
160 RESPIRATORY FAILURE 4 0.0001
161 PRURITUS 21 0.0001
162 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
163 HYPOCALCAEMIA 1 0.0001
164 LETHARGY 3 0.0001
165 EAR PAIN 1 0.0001
166 SKIN FISSURES 1 0.0001
167 CARDIAC FAILURE 4 0.0000
168 ILLNESS 5 0.0000
169 HYPOACUSIS 2 0.0000
170 RHINORRHOEA 3 0.0000
171 DEEP VEIN THROMBOSIS 3 0.0000
172 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
173 FAECES DISCOLOURED 1 0.0000
174 SWELLING FACE 3 0.0000
175 SEPTIC SHOCK 2 0.0000
176 RASH 20 0.0000
177 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
178 THROAT IRRITATION 2 0.0000
179 PANCREATITIS ACUTE 1 0.0000
180 HEPATIC ENZYME INCREASED 3 0.0000
181 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
182 ERYTHEMA 9 0.0000
183 MUSCLE TWITCHING 1 0.0000
184 HYPOKALAEMIA 2 0.0000
185 SWELLING 4 0.0000
186 DEVICE MALFUNCTION 3 0.0000
187 RASH ERYTHEMATOUS 2 0.0000
188 BLOOD GLUCOSE DECREASED 2 0.0000
189 NEURALGIA 1 0.0000
190 INJECTION SITE URTICARIA 1 0.0000
191 PERIPHERAL SWELLING 6 0.0000
192 DRUG RESISTANCE 1 0.0000
193 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
194 ANAPHYLACTIC SHOCK 1 0.0000
195 UNRESPONSIVE TO STIMULI 1 0.0000
196 SKIN ULCER 1 0.0000
197 RESPIRATORY TRACT INFECTION 1 0.0000
198 ARTHRITIS 3 0.0000
199 EAR INFECTION 1 0.0000
200 FEAR 1 0.0000
201 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
202 INFLUENZA LIKE ILLNESS 3 0.0000
203 RESPIRATORY ARREST 1 0.0000
204 ABNORMAL DREAMS 1 0.0000
205 INFLUENZA 4 0.0000
206 ANGINA PECTORIS 1 0.0000
207 NASAL CONGESTION 2 0.0000
208 URINARY INCONTINENCE 1 0.0000
209 CATARACT 2 0.0000
210 BLOOD POTASSIUM DECREASED 1 0.0000
211 DISCOMFORT 2 0.0000
212 LIMB DISCOMFORT 1 0.0000
213 DRUG-INDUCED LIVER INJURY 1 0.0000
214 HEAD INJURY 1 0.0000
215 CYSTITIS 1 0.0000
216 CHOLELITHIASIS 1 0.0000
217 DRUG INEFFECTIVE 40 0.0000
218 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
219 BLOOD PRESSURE DECREASED 2 0.0000
220 LIP SWELLING 1 0.0000
221 FUNGAL INFECTION 1 0.0000
222 URTICARIA 5 0.0000
223 EYE PRURITUS 1 0.0000
224 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
225 FLUSHING 3 0.0000
226 INJECTION SITE PAIN 9 0.0000
227 DELIRIUM 1 0.0000
228 COVID-19 5 0.0000
229 HEART RATE DECREASED 1 0.0000
230 LYMPHADENOPATHY 1 0.0000
231 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
232 INFECTION 4 0.0000
233 ACCIDENTAL OVERDOSE 1 0.0000
234 DYSURIA 1 0.0000
235 BRONCHITIS 2 0.0000
236 EYE SWELLING 1 0.0000
237 DYSPNOEA EXERTIONAL 1 0.0000
238 ARTHRALGIA 11 0.0000
239 CONDITION AGGRAVATED 8 0.0000
240 HOSPITALISATION 4 0.0000
241 INJECTION SITE BRUISING 2 0.0000
242 EXTRA DOSE ADMINISTERED 1 0.0000
243 FATIGUE 19 0.0000
244 OSTEOPOROSIS 1 0.0000
245 CARDIAC ARREST 2 0.0000
246 POLLAKIURIA 1 0.0000
247 ROAD TRAFFIC ACCIDENT 1 0.0000
248 COLITIS ULCERATIVE 1 0.0000
249 PULMONARY OEDEMA 1 0.0000
250 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
251 GASTROINTESTINAL DISORDER 2 0.0000
252 INCORRECT DOSE ADMINISTERED 5 0.0000
253 MEMORY IMPAIRMENT 3 0.0000
254 SKIN DISCOLOURATION 1 0.0000
255 NASOPHARYNGITIS 4 0.0000
256 HYPERSENSITIVITY 4 0.0000
257 PULMONARY EMBOLISM 2 0.0000
258 DISEASE RECURRENCE 1 0.0000
259 PRODUCTIVE COUGH 1 0.0000
260 HYPOGLYCAEMIA 1 0.0000
261 PAIN IN EXTREMITY 6 0.0000
262 HYPOTENSION 4 0.0000
263 FLUID RETENTION 1 0.0000
264 CHEST DISCOMFORT 2 0.0000
265 NERVOUSNESS 1 0.0000
266 SPEECH DISORDER 1 0.0000
267 PARAESTHESIA 3 0.0000
268 PANCREATITIS 1 0.0000
269 DEPRESSED MOOD 1 0.0000
270 ASTHENIA 7 0.0000
271 DISTURBANCE IN ATTENTION 1 0.0000
272 RASH PRURITIC 1 0.0000
273 OEDEMA 1 0.0000
274 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
275 NECK PAIN 1 0.0000
276 ABDOMINAL DISCOMFORT 3 0.0000
277 FLATULENCE 1 0.0000
278 MUSCULAR WEAKNESS 2 0.0000
279 HEADACHE 11 0.0000
280 HERPES ZOSTER 1 0.0000
281 PYREXIA 6 0.0000
282 BACK PAIN 4 0.0000
283 DYSPHONIA 1 0.0000
284 CHILLS 2 0.0000
285 DIARRHOEA 11 0.0000
286 WHEEZING 1 0.0000
287 IRRITABILITY 1 0.0000
288 JOINT SWELLING 2 0.0000
289 ILL-DEFINED DISORDER 1 0.0000
290 PLEURAL EFFUSION 1 0.0000
291 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
292 INJECTION SITE ERYTHEMA 2 0.0000
293 GAIT DISTURBANCE 3 0.0000
294 BLOOD CREATININE INCREASED 1 0.0000
295 DRY SKIN 2 0.0000
296 INJECTION SITE PRURITUS 1 0.0000
297 PRODUCT QUALITY ISSUE 2 0.0000
298 WEIGHT DECREASED 4 0.0000
299 BURNING SENSATION 1 0.0000
300 INJURY 1 0.0000
301 UNDERDOSE 1 0.0000
302 MALAISE 6 0.0000
303 PRODUCT DOSE OMISSION ISSUE 4 0.0000
304 EPISTAXIS 1 0.0000
305 HALLUCINATION 1 0.0000
306 INJECTION SITE SWELLING 1 0.0000
307 DECREASED APPETITE 3 0.0000
308 OFF LABEL USE 11 0.0000
309 PROSTATE CANCER 1 0.0000
310 PNEUMONIA 4 0.0000
311 TREATMENT FAILURE 1 0.0000
312 RENAL IMPAIRMENT 1 0.0000
313 SUICIDAL IDEATION 1 0.0000
314 ANXIETY 3 0.0000
315 DYSPHAGIA 1 0.0000
316 MIGRAINE 1 0.0000
317 CONTUSION 1 0.0000
318 DRUG INTOLERANCE 1 0.0000
319 ALOPECIA 2 0.0000
320 DYSPEPSIA 1 0.0000
321 NAUSEA 8 0.0000
322 SINUSITIS 1 0.0000
323 ABDOMINAL PAIN UPPER 2 0.0000
324 HAEMORRHAGE 1 0.0000
325 PLATELET COUNT DECREASED 1 0.0000
326 WEIGHT INCREASED 2 0.0000
327 DEPRESSION 2 0.0000
328 DISEASE PROGRESSION 1 0.0000
329 FEELING ABNORMAL 2 0.0000
330 PAIN 5 0.0000
331 DEATH 7 0.0000
332 VISUAL IMPAIRMENT 1 0.0000
333 INSOMNIA 2 0.0000
334 COUGH 2 0.0000
335 HYPOAESTHESIA 1 0.0000
336 BLOOD PRESSURE INCREASED 1 0.0000
337 ACUTE KIDNEY INJURY 1 0.0000
338 VOMITING 3 0.0000
339 FALL 2 0.0000
340 CEREBROVASCULAR ACCIDENT 1 0.0000
341 MYALGIA 1 0.0000
342 MYOCARDIAL INFARCTION 1 0.0000
343 MUSCLE SPASMS 1 0.0000
344 CHEST PAIN 1 0.0000
345 PRODUCT USE ISSUE 1 0.0000
346 BLOOD GLUCOSE INCREASED 1 0.0000
347 ANAEMIA 1 0.0000
348 SOMNOLENCE 1 0.0000
349 HYPERTENSION 1 0.0000
350 CONSTIPATION 1 0.0000
351 ABDOMINAL PAIN 1 0.0000
352 DIZZINESS 2 0.0000